Systemic immune and tissue repair networks

Systemic immune and tissue repair networks refer to the integrated physiological coordination between the immune system and various tissues to maintain homeostasis and facilitate healing after injury (Eming et al., 2017, Science Translational Medicine). These networks involve the recruitment of circulating immune cells, such as monocytes and T-cells, which migrate to damaged sites and interact with local fibroblasts and stem cells (Ginhoux & Guilliams, 2016, Immunity). Signaling molecules like IL-4, IL-10, and TGF-beta act as critical mediators within these networks to regulate the transition from inflammation to repair (Wynn & Vannella, 2016, Immunity). In a healthy context, these interactions ensure the timely resolution of inflammation and the restoration of tissue architecture; however, chronic dysregulation can lead to pathological conditions such as systemic fibrosis or chronic non-healing wounds (Medzhitov, 2008, Nature). Because this term describes a broad biological system encompassing numerous cell types and pathways, it is not classified as a single therapeutic target. Instead, pharmacological intervention typically targets specific nodes within these networks, such as cytokine receptors or signaling kinases, to modulate the overall repair response. Understanding these networks is essential for biotech analysts to evaluate therapies that aim to promote tissue regeneration while minimizing the risks of chronic inflammation or scarring.

Other names

Immune-tissue repair axisSystemic regenerative networksImmune-mediated wound healingImmune-tissue homeostasis

Not applicable as this is a biological network rather than a single target molecule.